Candel Therapeutics Inc (CADL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | |
| Sales | 0 | 31 | 31 |
| Gross Profit | N/A | 31 | 31 |
| Operating Expenses | 0 | 2,780 | 2,650 |
| Operating Income | N/A | -2,749 | -2,619 |
| Other Income | 0 | 195 | -257 |
| Pre-tax Income | 0 | -2,554 | -2,876 |
| Net Income Continuous | N/A | -2,554 | -2,876 |
| Net Income | $N/A | $-2,554 | $-2,876 |
| EPS Basic Total Ops | N/A | -0.22 | -0.25 |
| EPS Basic Continuous Ops | N/A | -0.22 | -0.25 |
| EPS Diluted Total Ops | N/A | -0.22 | -0.25 |
| EPS Diluted Continuous Ops | N/A | -0.22 | -0.25 |
| EBITDA(a) | $N/A | $-2,704 | $-2,619 |